| http://www.w3.org/ns/prov#value | - Gentium SpA (NASDAQ:GENT) - Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of drugs to treat and prevent various diseases and conditions, including vascular diseases related to cancer and cancer treatments.
|
